This study is looking at ways to improve care for children with sickle cell disease (SCD) when they visit the emergency department (ED) for a pain crisis. It's testing a "care pathway," which is a set of guidelines for how medical staff should manage these situations. The goal is to see if using this care pathway helps children receive pain medication (opioids) more quickly. You might be able to join if you are 18 years old or younger, have sickle cell disease, are visiting the ED for an uncomplicated pain crisis, and have received at least one opioid. You cannot join if you have acute chest syndrome, a fever over 38.5 degrees Celsius in the ED, priapism, or sickle cell trait. The study aims to enroll 5328 participants, but its current status is unclear.

Study design

This is an interventional study that plans to enroll 5328 participants. It is testing a care pathway as part of a hybrid type 2 implementation effectiveness study.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint measures the timeliness of receiving opioids, capturing all opioids received during the ED stay, up to a maximum of about 6 hours.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.